Janney Capital Initiates Tonix Pharmaceuticals At Buy

Janney Capital initiated coverage on

with a Buy rating. The target price for Tonix Pharmaceuticals is set to $10. Tonix Pharmaceuticals shares have dropped 29.58 percent over the past 52 weeks, while the S&P 500 index has surged 10.90 percent in the same period. Tonix Pharmaceuticals' shares fell 0.50 percent to close at $6.00 yesterday.